![Martyn Breeze](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martyn Breeze
No más puestos en curso
Historial de carrera de Martyn Breeze
Antiguos cargos conocidos de Martyn Breeze.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Amoebics Ltd.
![]() Amoebics Ltd. Pharmaceuticals: MajorHealth Technology Amoebics has developed a novel approach to tackle bacterial infections. Using a new technology, developed at Edinburgh University, Ameobics is producing antibacterial drugs that promise to be effective in the treatment of infections arising from bacteria, including bacteria that are resistant to treatment by antibiotics. The company was established in 1998 to commercialize work carried out in the laboratory of Dr. Sutherland Maciver in the Medical School of Edinburgh University. With a mix of equity and grant funding, the company has progressed its first product to the point of early preclinical testing. Results to date are very encouraging in terms of support for the firm's first product and also demonstrate the overall potential of the new technology to tackle a range of bacterial infections. | Director/Miembro de la Junta | - | 10/07/2013 |
PPL CORPORATION | Corporate Officer/Principal | - | - |
Celltech Group Plc
![]() Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
Reino Unido | 3 |
Estados Unidos | 2 |
Operativa
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Sectorial
Health Technology | 3 |
Utilities | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PPL CORPORATION | Utilities |
Empresas privadas | 2 |
---|---|
Amoebics Ltd.
![]() Amoebics Ltd. Pharmaceuticals: MajorHealth Technology Amoebics has developed a novel approach to tackle bacterial infections. Using a new technology, developed at Edinburgh University, Ameobics is producing antibacterial drugs that promise to be effective in the treatment of infections arising from bacteria, including bacteria that are resistant to treatment by antibiotics. The company was established in 1998 to commercialize work carried out in the laboratory of Dr. Sutherland Maciver in the Medical School of Edinburgh University. With a mix of equity and grant funding, the company has progressed its first product to the point of early preclinical testing. Results to date are very encouraging in terms of support for the firm's first product and also demonstrate the overall potential of the new technology to tackle a range of bacterial infections. | Health Technology |
Celltech Group Plc
![]() Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Martyn Breeze
- Experiencia